Old Web
English
Sign In
Acemap
>
Paper
>
Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases
Immunogenicity and safety of an inactivated virus vaccine against SARS-CoV-2 in patients with autoimmune rheumatic diseases
2021
Eloisa Bonfa
Ana Cristina de Medeiros Ribeiro
Nádia Emi Aikawa
Carla G. S. Saad
Emily Figueiredo Neves Yuki
Tatiana do Nascimento Pedrosa
Solange Regina Giglioli Fusco
Priscila Rojo
R. M. R. Pereira
Samuel Katsuyuki Shinjo
D.C.O. Andrade
Percival D. Sampaio-Barros
Carolina Torres Ribeiro
Giordano Deveza
Victor Adriano de Oliveira Martins
Clovis Artur Silva
Marta Heloisa Lopes
Alberto José da Silva Duarte
Leila Antonangelo
E. Sabino
Esper G. Kallas
Sandra Gofinet Pasoto
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]